Center of Excellence on Urologic Disease

The Center of Excellence (COE) on Urologic Disease will focus on discovering and implementing innovative treatments for the most prevalent urological disorders, including prostate cancer, bladder cancer, urinary tract infection and kidney stone disease.

For bladder cancer—the fourth most common cancer in men and eighth in women—one emphasis will be on investigating ways in which the bladder-specific cancer markers discovered here at NYU Langone Medical Center can be used to assess how well treatments are working.

• Read more about bladder cancer research at the COE
• Read more about translational prostate cancer research at the COE

NYU is already at the forefront of science in this field—one of the many avenues being explored at the Center is a novel version of a virus that specifically attacks tumor cells while sparing normal ones in both the prostate and the bladder. This version of the virus was engineered and patented by an NYU microbiologist.

Co-Directors:

• Herbert Lepor, M.D. Professor of Urology and Martin Spatz Chairman of the Department of Urology, Professor of Pharmacology
• Tung-Tien (Henry) Sun, Ph.D., Professor of Cell Biology, Rudolph L. Baer Professor of Dermatology, Professor of Pharmacology and Urology
• Xue-Ru Wu, M.D., Professor of Urology and Pathology
• View complete list of participants here

For more information on the Center of Excellence program, click here.